The European Innovation Council is a European Union institution that funds and accelerates deep-tech innovation across Europe. It provides substantial support to startups, researchers, and technology transfer activities through programs such as the EIC Accelerator, EIC Fund, and EIC Prizes, and offers business acceleration services to help scale and globally expand ventures. The council is described as a major investor, providing about €6.5 billion in funding, and it co-invests with private investors in early-stage startups with ESG impacts. Established in 2018 and headquartered in Brussels, it focuses on breakthrough innovations in deep technology, including dual-use and defence-relevant technologies, and engages with innovation ecosystems through events, reports, and information hubs. The organization is oriented toward advancing European competitiveness by nurturing high-potential tech ventures from inception through scaleup.

SOSV is a global venture capital firm focused on early-stage deep-tech and cross-border software companies, investing primarily from pre-seed through growth stages. It accelerates product development, regulatory progress, fundraising, and commercial strategy by providing founders access to purpose-built labs, engineering spaces, and a broad physical and virtual infrastructure across multiple locations. The firm's program-driven approach combines selective funding with hands-on support, mentorship, and a wide network of co-investors and partners to help portfolio companies scale. SOSV operates a suite of specialized facilities for deep-tech founders, including incubation programs that connect startups with customers, researchers, and investors, and it emphasizes long-term relationships through ongoing operational and strategic assistance. While active globally, it maintains strong ties to Asia-focused cross-border markets and supports a diverse portfolio spanning bio-tech, hardware, robotics, software, and related fields.

MassVentures is a Massachusetts-based venture capital firm focused on seed and early-stage investments that advance high-growth startups from concept to commercialization within the state’s innovation economy. Established in 1978 as a quasi-public entity by the Massachusetts Legislature and governed by an independent board, the firm funds ventures in deep tech and related sectors, including quantum computing, clean energy, biotech, artificial intelligence, advanced materials, manufacturing, and robotics. It has backed hundreds of companies and oversees more than $4 billion in follow-on capital, reflecting a durable track record of helping startups attract additional funding and scale. Beyond capital, MassVentures provides non-dilutive grants, commercialization support, mentorship, and strategic guidance through programs such as MV Capital and MV Accelerate, all aimed at building inclusive, connected ventures that leverage Massachusetts’ innovation ecosystem.

Navigare Ventures is a Stockholm-based venture capital firm focusing on early-stage science-driven companies in advanced computing and quantum technologies, synthetic biology and bio innovation, advanced materials and nanotechnology, and data-driven life science. Founded in 2021, it invests from seed through Series A and beyond, providing capital, strategic guidance, and access to networks across scientific and industrial communities to help portfolio companies grow. The firm emphasizes a long-term approach to translate research into industrial and societal impact, combining technical expertise with hands-on support to advance promising startups.

Shenzhen Capital Group is a government-backed venture capital firm based in Shenzhen that funds SMEs and high-tech companies across IT, internet, biotech, energy, materials and advanced manufacturing. It builds a nationwide innovation ecosystem by linking government, industry and academia to support early-stage to growth-stage ventures and facilitate cross-regional capital flows from the Greater Bay Area to the Western Silk Road. Guided by innovation, pragmatism and ESG, it prioritizes hard-tech and has backed a broad portfolio including semiconductors, robotics and medical technologies, with a history of helping companies scale and reach public markets.

Mitsubishi UFJ Capital is a Tokyo-based venture capital firm established in 1974 that specializes in seed and development-stage investments. It supports startups across information technology, life science, electronics, high technology, AI, biotech, fintech, and healthcare sectors with a focus on opportunities relevant to the Japanese market. The firm engages in investment syndication and maintains offices in Tokyo, Osaka, and Nagoya to facilitate regional deal flow and collaboration with MUFG affiliates. It aims to foster sustainable value creation by backing innovative companies at early and growth stages and by aligning portfolio activities with Japan’s technology and industry priorities.

Industrifonden is a Swedish evergreen venture capital firm founded in 1979 and based in Stockholm. It backs early-stage technology and life sciences companies with international potential, providing long-term support to entrepreneurs to help them scale and gain strategic credibility. The firm invests across Sweden and the Nordic region in seed, startup, development and expansion stages, often taking a board seat and co-investing with other investors. Its portfolio spans deep tech, AI, advanced materials, Industry 4.0, IT, life sciences and related sectors, including companies such as Qlik, Arcam, Soundtrack Your Brand, Fishbrain, CellaVision, Oncopeptides and AMRA. Industrifonden emphasizes patient capital and active involvement to build durable businesses rather than pursuing rapid exits.

Quantonation is a venture capital firm dedicated to quantum technologies, funding and mentoring early‑stage companies that translate quantum science into commercial products. Founded in 2018 and based in Paris with activities in Grenoble, it collaborates with leading research institutions and backs companies across quantum computing, sensing, cryptography, interconnects, and related areas such as molecular design and high‑performance computing. The firm provides strategic funding, mentorship, and access to industry collaborations to accelerate commercialization and help build a global quantum hardware and software ecosystem.

Founded in 2011, Shunwei Capital is a venture capital firm headquartered in Beijing, China. It invests in companies from early to growth stages, focusing on technology and internet businesses, including deep technology, smart manufacturing, consumer internet, enterprise services, and electric vehicles. Its investment activity centers on China and India, with cross-border investments also considered.

Alumni Ventures is a venture capital firm that invests in startups from seed through late-stage, including pre-IPO companies, and provides strategic capital and support to founders. It gives accredited investors access to diversified venture portfolios and co-investment opportunities, including investments in companies connected to alumni communities. The firm is based in Manchester, New Hampshire, and operates across North America, with additional offices in London and Tokyo.

Almi Invest is a Swedish early-stage venture capital firm headquartered in Stockholm and investing in startups across Sweden. It invests from pre-seed to Series A in areas including sustainability, industry, technology, and life sciences, typically alongside independent private investors. The firm also supports portfolio companies with strategic guidance, board participation, and access to its investor network.

Cottonwood Technology Fund is a venture capital firm that backs early-stage, high-tech and deeptech companies, focusing on patent-based hardware startups across sectors such as robotics, photonics, optics, nanotech, sensor technologies, telecom, automotive, cleantech, green energy, MedTech, chemicals and advanced materials. Founded in 2009, the firm operates in the Southwest United States and Northern Europe, with activities centered in Santa Fe, New Mexico and Enschede, Netherlands.

Innovation Industries is a Netherlands-based venture capital firm focused on deep-tech and technology-driven companies in Europe, with emphasis on hightech, medtech, agtech and agri-foodtech sectors. The firm pursues a hands-on investment approach, leveraging its team’s technical expertise, networks, and operational support to help entrepreneurs strengthen value propositions, accelerate time-to-market, and form strategic partnerships. It invests in early-stage ventures and can continue financing as they scale, aiming to be a true partner rather than only a financier. Based in Amsterdam, Innovation Industries seeks opportunities across startup and scale-up stages to back ventures that address global challenges with sustainable competitive advantages.

Legend Capital is a Beijing-based venture capital and growth investment firm founded in 2001 that concentrates on China-focused early-stage and growth opportunities across information technology, telecommunications, media, healthcare, consumer, enterprise services, and intelligent manufacturing. It backs ventures with strong ties to Chinese markets and provides resources for business development, branding, and market expansion in China. The firm maintains a multi-city presence in Beijing, Shanghai, Shenzhen and Hong Kong, and manages assets exceeding RMB 90 billion. Legend Capital has invested in more than 700 companies, with a substantial portfolio of exits and multiple IPOs and acquisitions realized in global markets, reflecting a track record of value creation in China's venture ecosystem. The approach combines global insights with a China-centric focus to support portfolio companies in scaling and internationalization.

Takwin Ventures is a venture capital firm and startup incubator based in Haifa, Israel. It supports early-stage, high-tech companies founded by Arab-Israeli entrepreneurs, primarily in Israel, with investment and practical help in areas such as business planning, product development, and strategy. Its investments span sectors including autonomous vehicles, agriculture technology, and nanotechnology.

Brabantse Ontwikkelings Maatschappij (BOM) is a regional development and investment organization based in Brabant, Netherlands. It supports startups and scale-ups by providing strategic financing, programmatic support, and pilots that accelerate growth and strengthen Brabant's innovation ecosystem. BOM concentrates on four priority areas: sustainable food, a healthy future, climate-neutral energy, and promising key technologies, and offers patient capital to help companies scale. Through its network of partners and internationalization activities, BOM connects Brabant firms with global markets and investors, aiming to create jobs, attract value-adding companies, and reinforce Brabant as a leading European innovation hub.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization based in Philadelphia that supports the region’s technology economy by providing capital, mentorship, and professional connections to technology companies across Southeastern Pennsylvania. Established in 1982, the program invests in early‑stage and established firms in information technology, health, and physical sciences, helping accelerate commercialization of scientific discoveries and strengthen the entrepreneurial community. It works with regional partners to attract investment and nurture startups into scalable businesses, contributing to job creation and regional economic development.

Foothill Ventures is a technology-focused venture capital firm based in Los Altos, California. Founded in 2011, it backs seed- to early-stage startups across software, life sciences, and frontier technologies, including robotics and physical AI, primarily in the United States. The firm operates as an early-stage investor and is described as a registered investment adviser.

Earlybird Venture Capital is a Europe-focused venture capital firm founded in 1997 and based in Berlin, with additional offices in Munich, Istanbul, and the United States. It invests in technology companies across development and growth stages, including software, artificial intelligence, fintech, health technology, mobility, the Internet of Things, and related digital sectors, focusing on European founders with selective U.S. opportunities. In addition to capital, Earlybird provides strategic support and access to an international network and capital markets. The firm manages over €2 billion and has a track record of portfolio exits, including 8 IPOs and 30 trade sales.

IQ Capital is a Cambridge-headquartered European deep-tech venture capital firm founded in 2005. It backs early-stage technology companies across sectors such as artificial intelligence, advanced computing and semiconductors, health tech, energy, and biology, focusing on frontier technologies that can become globally significant. The firm partners with founders from pre-seed to Series A, providing technical insight, strategic guidance, and access to a broad network to help startups achieve product-market fit and scale. It emphasizes rigorous technology due diligence and hands-on support to address technical challenges and go-to-market strategy. Through its portfolio, IQ Capital has backed companies that have been acquired by major technology players, reflecting its commitment to building enduring, globally competitive European businesses.

Imec.xpand is an independently managed venture capital firm based in Leuven, Belgium, with an additional office in Amsterdam. It invests in early-stage nanoelectronics-based innovation in the domains of deep tech, health, and agtech, aiming to accelerate the development and commercialization of technologies rooted in nanoelectronics. Backed by imec, the world-leading R&D hub for nanoelectronics and digital technology, imec.xpand leverages its connection to imec to support portfolio companies through technical expertise and access to a broad research ecosystem.

Puhua Capital is a Hangzhou-based venture capital firm that backs early- and mid-stage technology startups. It provides capital along with hands-on support, strategic guidance and ecosystem access to accelerate technology-to-market, focusing on hard-tech and future industries such as AI, semiconductors, robotics, biotechnology, energy, aerospace and digital infrastructure. The firm also invests in internet, health and technology sector startups and has backed nearly 300 startups.

Global Brain is an independent venture capital firm based in Tokyo, Japan, founded in 1998. It invests in technology startups worldwide, with a focus on sectors such as artificial intelligence, cloud software, cybersecurity, fintech, advertising technology, agriculture technology, climate tech, and related fields. The firm targets seed to growth-stage opportunities and collaborates with corporate venture partners to provide hands-on support and resources to portfolio companies. It maintains flagship funds and ongoing investment programs and has backed numerous startups with several notable exits, reflecting an emphasis on global expansion and practical value creation for early-stage and growth companies.

Chalmers Ventures is a deep-tech investor and venture builder based in Gothenburg, Sweden, embedded in the Chalmers entrepreneurial ecosystem in the Nordics. It operates on an evergreen model, reinvesting returns to support ongoing research and innovation, and provides in-house expertise and strategic capital to researchers, entrepreneurs, and startups from idea to exit. The firm targets seed through growth stages across sectors such as information technology, new materials, environmental engineering, medical technology, healthcare, water treatment, and finance, with a portfolio rooted in Sweden and the Nordic region. It focuses on turning breakthrough research into market-ready companies and is actively involved in technology transfer and startup development within its ecosystem.

Kyoto University Innovation Capital is the venture investment arm of Kyoto University, established in December 2014 with 100% funding from the university to commercialize its research outputs. It focuses on seed to early-stage investments in startups commercializing university-originated science and technologies, across fields such as biopharma, therapeutics, medtech, diagnostics, climate and sustainability, computing and frontier technologies, industrial deep tech, and food and AgTech. It supports portfolio companies through capital and programming, notably the ECC-iCAP program, which connects researchers with business professionals, and the EIR-iCAP guest entrepreneur initiative that enables spin-outs with venture-capital backing. The organization is headquartered in Kyoto, Japan.

Bayern Kapital is the venture capital arm of LfA Förderbank Bayern, Bavaria’s development bank. It finances research and development and the market introduction of new products, product diversification, and expansion of market share for Bavarian companies. The firm invests in high-tech sectors including information technology, life sciences, micro-systems, nanotechnology, materials, software, and environmental technologies, and targets small and medium-sized enterprises located in Bavaria. It supports startups from early stages through expansion and growth, offering equity and other forms of financing, with ticket sizes typically ranging from hundreds of thousands to tens of millions of euros. By leveraging its network and three decades of venture experience, Bayern Kapital seeks to sustain long-term innovation in Bavaria and to help portfolio companies scale domestically and internationally.

Oriza Seed Capital is a market‑oriented investment platform based in Suzhou Industrial Park. It seeks early‑stage and growth‑stage opportunities in the healthcare and TMT sectors. The firm has substantial experience and resources in healthcare investing, having backed more than 50 companies by March 2016, including Ascentage Pharma, Innovent Biologics, and SceneRay.

BeAble Capital is a Spanish science-focused venture capital firm that operates at pre-seed to early stages, emphasizing science-based technologies and technology transfer. It targets advanced materials, nanotechnology and biotechnology, photonics, micro and nano electronics, and ICT platforms, prioritizing strong intellectual property and long R&D backgrounds. The firm connects scientific research with entrepreneurship to identify technologies, value them, facilitate transfer, create startups, and support fundraising, marketing, internationalization and management expertise. It backs startups across mobility, materials science, biotechnology, sustainability and related fields, including efforts to extend product lifecycles and reduce environmental impact, with recent activity highlighting AI integration within the deep-tech space. BeAble Capital seeks to foster technological re-industrialization in Spain and Europe by providing strategic and operational support to innovative ventures throughout early development stages.

Cornerstone Venture Capital is a Beijing-based venture capital firm, founded in 2011, that focuses on investments in rail transit, information technology, information security, advanced manufacturing, and clean technology sectors.

IDG Capital is a global venture capital and private equity firm established in 1993 and headquartered in Hong Kong, with operations across three continents and more than 300 investment professionals. It provides funding across stages including venture capital, growth, buyout and secondary markets, and backs companies in technology, consumer, media, healthcare, energy and information technology sectors. The firm guides a large portfolio of companies and has supported hundreds of exits, leveraging a global ecosystem to offer strategic resources and partnerships. Its investor roster includes sovereign wealth funds, pension funds and other institutional investors, enabling diverse capital and long-term collaboration with founders.

The Invus Group is a long-standing private equity firm founded in 1985 and based in New York. It partners with entrepreneurs to drive transformative growth across sectors including consumer products and services, technology, life sciences, software, and industrials. The firm emphasizes long-term collaboration, aligns incentives with management, and provides both capital and strategic advisory to help portfolio companies scale internationally. It maintains a global presence with offices in the United States, Europe, and Asia, and pursues flexible investment approaches through evergreen capital structures and co-investment opportunities. The group supports management-led buyouts, growth equity, and select opportunistic investments, aiming to create lasting value rather than short-term gains.

Hua Capital is a Beijing-based venture capital and private equity firm established in 2014, focused on semiconductors and related hard-tech sectors. It pursues investments in integrated circuits, artificial intelligence, new materials, robotics, photonics and quantum technologies, smart manufacturing and brain-computer interfaces. The firm emphasizes professional, international, and industry-chain oriented investing, drawing on a team with extensive entrepreneurship and investment experience. It is associated with prominent investors such as Tsinghua Holdings and China Fortune-Tech Capital, which support its strategy of helping portfolio companies scale and compete as leaders in the semiconductor ecosystem.

OrbiMed is a global healthcare investment firm based in New York, founded in 1989. It manages capital across public and private markets, including private equity, venture and growth investments, and private credit, with structured debt and royalty arrangements to support owners of intellectual property and diagnostics. The firm focuses on biopharmaceuticals, life sciences, medical devices, diagnostics, health IT, and healthcare services, investing from startups to multinational companies. With a worldwide team and offices in multiple regions, OrbiMed provides financing and strategic resources to advance therapies and healthcare innovations, aiming to improve patient outcomes across global markets.

RA Capital Management is a Boston-based investment firm specializing in healthcare, life sciences, and planetary health. It pursues evidence-based, science-led investing through its internal TechAtlas research engine and supports portfolio companies via its Raven healthcare incubator. The firm engages across stages from seed funding to IPOs and follow-on financings, focusing on drugs, medical devices, diagnostics, and other biomedical innovations, with a regional emphasis on the United States and Europe.

LYFE Capital is a global healthcare investment firm with about 2 billion USD in assets under management. It operates from five offices across North America, Asia, and Europe, including Menlo Park, US; Singapore; Seoul; Tokyo; and Shanghai, leveraging global resources to invest in healthcare companies. The firm targets critical healthcare supply chain assets, specialized product platforms, and R&D services to help portfolio companies scale and deliver consistent returns to institutional investors. Its investments span medical devices, therapeutics, diagnostics, and related sectors, with an emphasis on strategic partnerships and M&A integration to accelerate growth across markets.

Molten Ventures is a London-based European venture capital firm that backs high-growth private technology companies across Europe. The firm invests across the lifecycle—from seed to growth—targeting disruptive sectors such as spacetech, fintech, AI, deeptech, consumer tech, healthtech, SaaS, and enterprise software. It combines multiple pools of capital to provide not only funding but also strategic expertise, networks, and partnerships to help portfolio companies scale and pursue high-value exits through acquisitions, trade buyouts, or IPOs. With a long-standing track record and experience spanning roughly two decades, Molten Ventures supports founders and innovators by fostering collaboration and value creation, including a Growth Fund with commitments from institutions such as the British Business Bank, to fuel the next generation of European tech leaders.

Northern Light Venture Capital is a venture capital firm founded in 2005 and based in Menlo Park, California. It pursues early and growth-stage investments across information technology, new media, TMT, clean technologies, consumer services, healthcare, and enterprise sectors, with a China-focused approach that seeks to leverage China’s industrial, economic, and human resources to build lasting global enterprises. The firm has backed notable technology and internet portfolio companies as part of its investment activity.

Avoro Capital is a global life sciences investment firm based in New York that focuses on supporting emerging biotechnology companies. It pursues thoughtful, long-term investments in biotech and related equity opportunities, with an emphasis on early-stage companies and privately held ventures. The firm provides comprehensive support throughout the investment lifecycle and employs vigilant risk management, including hedging and careful portfolio construction. Avoro seeks to advance biopharmaceutical innovation by addressing unmet medical needs and capitalizing on opportunities arising from pharmaceutical partnerships and M&A activity. The approach centers on intellectual curiosity and identifying undervalued opportunities within the rapidly evolving biotechnology sector, aiming to create value for portfolio companies and investors alike.

Northstar Ventures is a Newcastle upon Tyne based venture capital firm that backs early- and growth-stage technology companies in the United Kingdom, with a focus on climate technology and healthy ageing. The firm provides capital and strategic support through its network of universities, funders, non-executive directors, and talent to help portfolio companies scale, innovate, and create regional growth. It primarily invests in the United Kingdom, with emphasis on the North East England region, including County Durham, Northumberland, and Tyne and Wear, and aims to support startups that drive employment, skills development, and positive social impact.

Source Code Capital is a Beijing-based venture capital firm founded in 2014 that invests across seed, early and growth stages in China, focusing on TMT and the Big 3 drivers: Internet+, AI+ and Global+. It backs startups across sectors such as finance, media and entertainment, consumer services, enterprise, retail, transportation, housing, education, and healthcare, and has supported more than 300 companies including ByteDance, Meituan, Beike, Li Auto, OPay and Stori. The firm operates a post-investment platform and Code Market, an ecosystem that provides mentoring, resources and connections to help founders scale, combining macro, meso and micro perspectives, data and technology to create durable value for the ecosystem.

CDP Venture Capital is a leading Italian venture capital fund manager that oversees about €4.9 billion in assets under management across 15 direct and indirect funds. The firm concentrates its investments in sectors integral to Italy’s growth, aiming to place entrepreneurship at the center of economic development. It supports a mature portfolio, pursues ecosystem collaborations to strengthen investments and innovation, and is expanding through new vehicles such as Ulixes and Lumen Ventures' Lumen II, a seed-stage fund focused on insurtech, fintech, digital health, and cybersecurity. CDP maintains a substantial presence in Rome and Milan and offers opportunities through programs like XJOBS. The organization emphasizes transparency through regular investor materials and annual reports, reinforcing its role in advancing the venture capital ecosystem in Italy.

Union Investment Partners is a venture capital firm based in Seoul, South Korea, focused on contents investments in media and related sectors, including films, animations, games, TV dramas, and live events. The firm aims to be a major investment partner for venture businesses and the contents industry seeking growth and global reach, and also invests across a broader range of sectors such as media, mobile, platform, biotechnology, healthcare, brand, distribution, and semiconductors.

Stockholms Affärsänglar is a Stockholm-based venture group that combines angel investing with venture capital activities. Founded in 2008, it focuses on early-stage, research-based spin-outs and B2B startups in the Nordic region, with interests in life sciences, advanced industrial technologies, ICT, and sustainable energy. The group seeks to support ventures with an active involvement, leveraging a network of experienced partners to provide capital and strategic guidance.

Boxer Capital is a biotech investment firm and the corporate venture capital arm of Tavistock Group, based in San Diego, California. The firm invests in biotechnology and precision medicine companies across private and public markets, spanning the drug development lifecycle from early discovery to late-stage development and commercialization, with a focus on oncology and novel targets. It emphasizes scientific expertise and a disciplined, research-driven due diligence process that includes clinical, regulatory, and commercial assessment. Boxer Capital maintains independent investment decisions and has partnered with portfolio companies such as Mirati Therapeutics to support growth. The firm seeks opportunities in specialized medicine, precision oncology, and related life sciences sectors.

ARCH Venture Partners is a venture capital firm founded in 1986 and based in Chicago, Illinois, with additional operations in Seattle. The firm focuses on science-based companies, prioritizing life sciences and related technologies, and aims to translate academic and national lab innovations into commercially viable products. ARCH emphasizes a true partnership approach, providing capital alongside strategic guidance, expertise, and a broad professional network to founders. It has supported numerous companies across early to growth stages and is known for backing translational efforts that bring breakthrough discoveries to market, leveraging collaborations with researchers and entrepreneurs to accelerate development of disruptive technologies on a national and international scale.

Gaorong Capital is a Beijing-based venture investment firm that backs early-stage technology companies in Asia-Pacific. Founded around 2013, it focuses on technology sectors including telecommunications, media, life sciences, cosmetics, and other tech, providing strategic resources and global perspectives to portfolio companies through a diverse base of limited partners and industry executives, including sovereign wealth funds, university endowments, pension funds, and leaders from Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop.

Anda Asia Ventures is a venture capital firm headquartered in Seoul, South Korea. It concentrates on early- and growth-stage investments in technologies shaping the Fourth Industrial Revolution, including artificial intelligence, big data, information and communications technology, biotechnology, materials, and components. The firm supports startups across these sectors, aiming to foster innovation and the development of scalable solutions in the 4IR ecosystem.

Wonik Investment Partners is a private equity and venture capital firm based in Seoul, South Korea, founded in 1997 and formerly known as Hanmi Technology Investment. It targets incubation, start-up, early and mid-stage, and growth capital investments as well as corporate restructuring. The firm prefers opportunities in gaming content, electronic components, computers and telecommunications equipment, petroleum and energy, machinery and equipment, and emerging sectors such as electric and self-driving vehicles, smart ships, Internet of Things appliances, robotics, biotechnology and healthcare, aviation and drones, premium consumer goods, new energy, advanced materials, virtual and augmented reality, next generation displays, and next generation semiconductors. It seeks exits through initial public offerings or mergers and acquisitions.

180 Degree Capital is an investment firm based in Montclair, New Jersey, focusing on technology, nanotechnology, energy, clean technology, healthcare, and electronics sectors, and it pursues investments in companies within these areas.

BioVenture is a Suzhou-based investment firm focused on early and growth-stage healthcare in the life sciences sector with a global outlook. Since its founding in 2013, it has invested in more than 200 life sciences companies across four core areas—new drug discovery, medical devices, diagnostics and precision medicine, and healthcare services—with 19 portfolio companies having gone public on HKEX or the STAR Market. The firm operates four platforms—pharma/biotech, devices, diagnostics and precision medicine, and medical services—leveraging extensive industry resources and partnerships to drive portfolio growth. It emphasizes post-investment management and value-added services, supported by a team of experienced investment professionals and senior scientific advisors. Through a platform network anchored in bioBAY at Suzhou Industrial Park, BioVenture is regularly recognized among China’s top healthcare venture capital firms and remains active in funding innovative medical and pharmaceutical ventures.